Muecke Company, Incorporated v. CVS Caremar

615 F. App'x 837
CourtCourt of Appeals for the Fifth Circuit
DecidedAugust 25, 2015
Docket14-41213
StatusUnpublished
Cited by2 cases

This text of 615 F. App'x 837 (Muecke Company, Incorporated v. CVS Caremar) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Muecke Company, Incorporated v. CVS Caremar, 615 F. App'x 837 (5th Cir. 2015).

Opinion

PER CURIAM: *

Several independent retail pharmacies appeal the district court’s grant of a motion to compel arbitration of their RICO and misappropriation of trade secrets claims against several CVS entities. A recent decision from our circuit has almost entirely disposed of the issue. Consequently, we AFFIRM.

FACTS AND PROCEDURAL BACKGROUND

The plaintiffs are independent retail pharmacies ip Texas that filed claims against several CVS entities for racketeering, trade secret misappropriation, and violations of the Texas Any Willing Provider Law 1 in September 2010. In their RICO/ trade secret claims, the plaintiffs alleged CVS used the plaintiffs’ patients’ names and health information to market CVS products and services to the plaintiffs’ customers. The plaintiffs claim those names and the information were trade secrets and that CVS misappropriated them.

The defendants moved to compel arbitration pursuant to an arbitration provision in the provider agreements. Only one of the defendants was a signatory; all of the plaintiffs were signatories. The defendants based their motion on equitable es-toppel, contending that the plaintiffs should not be allowed to raise claims based on the provider agreements while simultaneously avoiding the arbitration provision. There was no dispute that Arizona law controlled the interpretation of the provider agreements. Applying Arizona law, the magistrate judge recommended against compelling arbitration for the non-signatory defendants because he found that’ the claims could be litigated without reference to the contracts containing the arbitration provision. The magistrate judge stated: “The only relevance of the provider agreements to these claims is to explain how [the] [defendants obtained the information in the first place.”

*839 The district court adopted the magistrate judge’s memorandum and recommendations. It ordered arbitration between the plaintiffs and the lone signatory defendant, Caremark, L.L.C. It stayed claims against the non-signatory defendants— CVS Caremark, CVS Pharmacy, and Care-mark Rx — pending the completion of arbitration to avoid inconsistent outcomes and comply with the Federal Arbitration Act.

The non-signatory parties appealed to this court. We affirmed in a short, unpublished opinion, holding that under the abuse of discretion standard, the district court did not err in denying the motion to compel arbitration with regard to the non-signatories. Muecke Co. v. CVS Caremark Corp., 512 Fed.Appx. 395 (5th Cir.2013) (“Muecke I”).

The plaintiffs did not initiate arbitration. Instead, they waited until the time expired for the defendants to seek review of Muecke I by the United States Supreme Court. Once that period ended, they moved to dismiss the claims that were to be arbitrated against Caremark, L.L.C. After briefing on both the voluntary dismissal and lifting of the stay pending arbitration, the district court granted the dismissal of the sole signatory defendant, Caremark, L.L.C., and lifted the stay as to the other defendants. The district court reminded the plaintiffs that if they later raised any issue related to the contracts the court would again compel arbitration even with regard to the remaining non-signatories.

In April 2014, this court issued a prece-dential opinion in a related case. See Crawford Prof'l Drugs, Inc. v. CVS Caremark Corp., 748 F.3d 249 (5th Cir.2014). That suit involved similarly situated plaintiffs who sued Caremark, L.L.C., CVS Caremark, CVS Pharmacy, and Caremark Rx. Id. at 254. The plaintiffs asserted trade secret misappropriation claims as well as other claims. Id. It is undisputed that Caremark, L.L.C. and the Crawford plaintiffs entered into the same provider agreements that are at issue here. Id. Three of the Crawford defendants were non-signatories to the provider agreements, but all four moved to compel arbitration. Id.

The Crawford plaintiffs argued that they should not be compelled to arbitrate claims against non-signatories, their claims were not subject to the provider agreements, and the provider agreements and the provider manual’s arbitration clause were procedurally and substantively unconscionable under Mississippi law. Id. at 254-55. This court recognized, as did the district court in Muecke I, that the Supreme Court has held that the Federal Arbitration Act permits state-law contract theories such as equitable estoppel to compel arbitration against nonparties. Arthur Andersen LLP v. Carlisle, 556 U.S. 624, 630, 129 S.Ct. 1896, 173 L.Ed.2d 832 (2009). Applying that concept, this court held that “[t]he relevant Arizona law, made controlling by the Provider Agreement’s choice-of-law clause, supports the non-signatory [defendants’ motion to enforce the agreement to arbitrate ... based on state-law equitable estoppel doctrine.” Crawford, 748 F.3d at 255.

The Crawford court found that Arizona case law on equitable estoppel was unhelpful, so it followed the Arizona Supreme Court’s direction to consider California law in the absence of relevant Arizona law. Id. at 260. It identified a California Supreme Court decision advising courts to consider whether “ ‘claims against the [non-signatory defendants] are founded in and inextricably bound up with the obligations imposed by the agreement containing the arbitration clause’” when determining whether to apply equitable estoppel to an arbitration agreement. Id. (quoting *840 . Goldman v. KPMG LLP, 173 Cal.App.4th 209, 92 Cal.Rptr.3d 534, 541 (2009)). The court held that under the elements of the plaintiffs’ trade secret claims, they needed to prove the defendants gained the secrets through “breach of a confidential relationship or discover[y] by improper means.” Id. at 261 (citation and quotation marks omitted). Because the plaintiffs alleged they voluntarily gave the information to the defendants, the plaintiffs would have to demonstrate that the defendants’ use of the information had “exceeded the scope of their permitted use....” in the provider agreements. Id. Thus, the plaintiffs’ claims were “ ‘inextricably bound up with the obligations imposed by the agreement containing the arbitration clause.’ ” Id. (quoting Goldman, 92 Cal.Rptr.3d at 541).

The remaining defendants in the current case, relying on Crawford, filed a motion for reconsideration of the court’s decision on arbitration. The magistrate judge recommended reconsideration because it found that Crawford was an intervening change in the law. The magistrate judge had used a “derived-benefit standard” to determine that the plaintiffs were not claiming any benefit under the contract, but the Crawford court held that the elements of the plaintiffs’ trade secret misappropriation claims should be considered.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

O'Brien & Assocs. Co., L.P.A. v. E. Worthington, L.L.C.
2023 Ohio 3494 (Ohio Court of Appeals, 2023)
West Virginia CVS Pharmacy, LLC v. McDowell Pharmacy, Inc.
796 S.E.2d 574 (West Virginia Supreme Court, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
615 F. App'x 837, Counsel Stack Legal Research, https://law.counselstack.com/opinion/muecke-company-incorporated-v-cvs-caremar-ca5-2015.